Simplified neuropathological diagnosis of dementia with Lewy bodies

Neuropathology and Applied Neurobiology

Volumn 24, Issue 3, 1998, Pages 195-201

  Harding, A J ^a   Halliday, G M ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Dementia with Lewy bodies; Diagnostic criteria; Diffuse Lewy body disease; Neuropathology; Parkinson's disease; Semiquantification

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTICLE; ASSOCIATION CORTEX; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; FRONTAL LOBE; HUMAN; HUMAN TISSUE; LEWY BODY; NEUROPATHOLOGY; PARIETAL LOBE; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; BRAIN; DEMENTIA; HUMANS; INCLUSION BODIES; LEWY BODIES; MIDDLE AGED; PARKINSON DISEASE; PATHOLOGY; UBIQUITINS;

EID: 0031874688     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1998.00115.x     Document Type: Article

References (38)

1. Armstrong RA, Cairns NJ, Lantos PL. beta-Amyloid (A. beta) deposition in the medial temporal lobe of patients with dementia with Lewy bodies. Neurosci Lett 1997; 227: 193-6
2. Armstrong RA, Cairns NJ, Lantos PL. Dementia with Lewy bodies: clustering of Lewy bodies in human patients. Neurosci Lett 1997; 224: 41-4
3. Bancher C, Braak H, Fischer P, Jellinger KA. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 1993; 162: 179-82
4. Braak H, Braak E. Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex. J Neural Transmiss 1990; 2: 45-57
5. Daniel SE. Parkinson's disease. In Neuropathological Diagnostic Criteria for Brain Banking. Eds FF Cruz-Sanchez, R Ravid, ML Cuzner. IOS Press, Amsterdam, 1995: 72-79
6. Duyckaerts C, Gaspar P, Costa C, Bonnet AM, Hauw JJ. Dementia in Parkinson's disease. Morphometric data. Adv Neurol 1993; 60: 447-55
7. Garvey W, Fathi A, Bigelow F, Jimenez CL, Carpenter BF. Rapid, reliable and economical silver stain for neurofibrillary tangles and senile plaques. J Histochemical 1991; 14: 39-42
8. Gentleman SM, Williams B, Royston MC et al. Quantification of beta A4 protein deposition in the medial temporal lobe: a comparison of Alzheimer's disease and senile dementia of the Lewy body type. Neurosci Lett 1992; 142: 9-12
9. Gibb WR, Luthert PJ, Janota I, Lantos PL. Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiat 1989; 52: 185-92
10. Hansen LA. Tautological tangles in neuropathologic criteria for dementias associated with Lewy bodies. In Dementia with Lewy Bodies, Clinical, Pathological, and Treatment Issues. Eds RH Perry, IG McKeith, EK Perry. Cambridge University Press, Cambridge, 1996: 204-211
11. Hansen LA, Galasko D. Lewy body disease. Curr Opin Neurol Neurosurg 1992; 5: 889-94
12. Hansen LA, Masliah E, Quijada-Fawcett S, Rexin D. Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies. Neurosci Lett 1991; 129: 269-72
13. Hughes A, Daniel S, Kilford L, Lees A. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiat 1992; 55: 181-4
14. Ince P, Irving D, MacArthur F, Perry R. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type. Parkinson's disease and non-demented elderly control patients. J Neurol Sci 1991; 106: 142-52
15. Jellinger K, Braak H, Braak E, Fischer P. Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Ann N Y Acad Sci 1991; 640: 203-9
16. Jendroska K, Lees AJ, Poewe W, Daniel SE. Amyloid beta-peptide and the dementia of Parkinson's disease. Movement Disorders 1996; 11: 647-53
17. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990; 237: 197-204
18. Kosaka K, Iseki E. Diffuse Lewy body disease within the spectrum of Lewy body disease. In Dementia with Lewy Bodies, Clinical, Pathological, and Treatment Issues. Eds RH Perry, IG McKeith, EK Perry. Cambridge University Press, Cambridge, 1996: 238-247
19. Kosaka K, Iseki E, Odawara T, Yamamoto T. Cerebral type of Lewy body disease. Neuropathology 1996; 16: 32-5
20. Kuzuhara S, Yoshimura M, Mizutani T, Yamanouchi H, Ihara Y. Temporal lobe immunohistochemical pathology for tangles, plaques and Lewy bodies in diffuse Lewy body disease, Parkinson's disease, and senile dementia of Alzheimer type. In Dementia with Lewy Bodies, Clinical, Pathological, and Treatment Issues. Eds RH Perry, IG McKeith, EK Perry. Cambridge University Press, Cambridge, 1996: 248-254
21. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiat 1989; 52: 1236-47
22. Lippa CF, Pulaski-Salo D, Dickson DW, Smith TW. Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway. J Neurol Sci 1997; 147: 161-6
23. Mann DM, Snowden JS. The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. Acta Neuropathol 1995; 89: 178-83
24. Masliah E, Mallory M, DeTeresa R, Alford M, Hansen L. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Res 1993; 617: 258-66
25. McKeith IG, Galasko G, Kosaka K et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-24
26. Mega MS, Masterman DL, Benson DF et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996; 47: 1403-9
27. Mirra SS, Heyman A, McKeel D, Crain BJ, Brownlee LM, Vogel FS. The consortium to establish a registry for Alzheimers disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86
28. Morris JC, Heyman A, Mohs RC et al. The consortium to establish a registry for Alzheimers disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39: 1159-65
29. Pellise A, Roig C, Barraquer-Bordas LI, Ferrer I. Abnormal, ubiquitinated cortical neurites in patients with diffuse Lewy body disease. Neurosci Lett 1996; 206: 85-8
30. Perry EK, McKeith I, Thompson P et al. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann N Y Acad Sci 1991; 640: 197-202
31. Rezaie P, Cairns N, Chadwick A, Lantos P. Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Lett 1996; 212: 111-4
32. Samuel W, Alford M, Hofstetter CR, Hansen L. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol 1997; 56: 499-508
33. Samuel W, Crowder R, Hofstetter CR, Hansen L. Neuritic plaques in the Lewy body variant of Alzheimer disease lack paired helical filaments. Neurisci Lett 1997; 223: 73-6
34. Samuel W, Galasko D, Masliah E, Hansen LA. Neocortical Lewy body counts correlate with dementia in the lewy body variant of Alzheimer s Disease. J Neuropathol Exp Neurol 1996; 55: 44-52
35. Schmidt ML, Martin JA, Lee VM, Trojanowski JQ. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol 1996; 91: 475-81
36. Schmidt ML, Murray J, Lee VM, Hill WD, Wertkin A, Trojanowski JQ. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 1991; 139: 53-65
37. Sugiyama H, Hainfellner JA, Yoshimura M, Budka H. Neocortical changes in Parkinson's disease, revisited. Clin Neuropathol 1994; 13: 55-9
38. Wakabayashi K, Hansen LA, Masliah E. Cortical Lewy body-containing neurons are pyramidal cells: laser con focal imaging of double-immunolabeled sections with antiubiquitin and SMI32. Acta Neuropathol 1995; 89: 404-8